Watch for Three New Antiepileptics

August 2014

You'll see three new antiepileptic drugs called Qudexy XR (cue-DEKS-ee), Fycompa (fi-COM-puh), and Aptiom (AP-tee-om).

Qudexy XR (topiramate extended-release) will compete with Trokendi XR as a once-daily alternative to topiramate immediate-release.

These once-daily brands will cost $140 to $560/month for 25 to 200 mg/day...compared to under $30/month for topiramate immediate-release.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote